Inhaltsverzeichnis der aktuellen Ausgabe (4. Quartal 2001) Herstellung, Lagerung, Transport und Qualitätskontrolle Blutprodukten Current strategies for the provision of safer plasma and its derivatives: an update
Evidence-based recommendations for the use of WBC-reduced cellular blood components
Bacterial contamination of platelet concentrates: incidence, significance, and prevention
Autologe Hämotherapie und Alternativen zur Bluttransfusion
Patient factors affecting autologous and allogeneic blood transfusion rates in total hip arthroplasty
Aprotinin reduces blood loss and the need for transfusion in orthognathic surgery
A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery
Limited effectiveness of intraoperative autotransfusion in major back surgery
The effect of acute normovolaemic haemodilution on blood transfusion requirements in abdominal aortic aneurysm repair
Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: a prospective study
A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery
Intraoperative cell salvage in radical retropubic prostatectomy
Humoral immune response to autologous blood transfusion in hip surgery: whole blood versus packed red cells and plasma
Cellular immune response to autologous blood transfusion in hip arthroplasty: whole blood versus buffy coat-poor packed red cells and fresh-frozen plasma.
The type of storage of autologous blood does not influence homologous transfusion requirements in hip arthroplasty
Therapie mit Erythrozyten Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients
Therapie mit Plasmaprodukten
Recombinant Factor VIIa (NovoSeven®) as a hemostatic agent
Advances in the treatment of von Willebrand disease
Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis
Spezielle Haemotherapie in der konservativen Medizin Recombinant Factor VIIa (NovoSeven®) as a hemostatic agent
Advances in the treatment of von Willebrand disease
Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis Spezielle Haemotherapie in der operativen Medizin Prevention and therapy of hemostatic disorders in massive transfusion
Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients Immunhämatologische Labormethoden Antibody Magnitude Score: a new concept combining the extent and the strength of alloantibody Unerwünschte Wirkungen von Blutprodukten Evidence-based recommendations for the use of WBC-reduced cellular blood components
Significance of allogenic blood transfusion on decreased survival in patients with esophageal carcinoma
Creutzfeldt-Jakob disease and blood transfusions: a meta-analysis of case-control studies
Bacterial contamination of platelet concentrates: incidence, significance, and prevention
HLA class II antibodies in transfusion-related acute lung injury |